1325 AVENUE OF AMERICAS, NEW YORK, NY
Exhibit 99.1
Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
Announces First Quarter 2026 Financial Results and Provides Corporate Update
Announces Full Year 2025 Financial Results and Provides Corporate Update
Securities Purchase Agreement - Brainstorm Cell Therapeutics Raises $1M
Brainstorm Cell Therapeutics Enters $1M Securities Purchase Agreement
Brainstorm Cell Therapeutics Inc. Issues Promissory Notes Totaling $94,300
Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
RW
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload